Calliditas Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CALT and buy or sell other stocks, ETFs, and their options commission-free!About CALT
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications.
CEORenée Julie Elisabet Aguiar-Lucander, MBA
CEORenée Julie Elisabet Aguiar-Lucander, MBA
Employees—
Employees—
HeadquartersStockholm, Stockholm
HeadquartersStockholm, Stockholm
Founded2004
Founded2004
Employees—
Employees—
CALT Key Statistics
Market cap1.07B
Market cap1.07B
Price-Earnings ratio-23.64
Price-Earnings ratio-23.64
Dividend yield—
Dividend yield—
Average volume2.49K
Average volume2.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$43.00
52 Week high$43.00
52 Week low$15.25
52 Week low$15.25
Stock Snapshot
As of today, Calliditas Therapeutics(CALT) shares are valued at $40.00. The company's market cap stands at 1.07B, with a P/E ratio of -23.64.
Calliditas Therapeutics(CALT) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Calliditas Therapeutics(CALT) shares are trading with a volume of 0, against a daily average of 2.49K.
In the last year, Calliditas Therapeutics(CALT) shares hit a 52-week high of $43.00 and a 52-week low of $15.25.
In the last year, Calliditas Therapeutics(CALT) shares hit a 52-week high of $43.00 and a 52-week low of $15.25.